Last update 14 Jun 2026

IntegerBio, Inc.

Holding Company|2020|Maryland, United States|
www.integer.bio

Overview

Tags

Digestive System Disorders
Infectious Diseases
Monoclonal antibody

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms1
Infectious Diseases1
Endocrinology and Metabolic Disease1
Top 5 Drug TypeCount
Monoclonal antibody1
Top 5 TargetCount
BAG3(BAG cochaperone 3)1

Related

1
Drugs associated with IntegerBio, Inc.
IB-001
Target
BAG3
Mechanism
BAG3 inhibitors
Active Org.
Intrepida Bio, Inc.Intrepida Bio, Inc.
 [+1]
Originator Org.
Intrepida Bio, Inc.Intrepida Bio, Inc.
Active Indication
Hepatitis B, Chronic [+1]
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with IntegerBio, Inc.
NCT07389044
/ RecruitingPhase 1
A Phase 1, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics, And Preliminary Efficacy of Single and Multiple Ascending Doses of IB-001 in Healthy Participants and Participants With Chronic Hepatitis B
100 Clinical Results associated with IntegerBio, Inc.
Login to view more data
0 Patents (Medical) associated with IntegerBio, Inc.
Login to view more data
100 Deals associated with IntegerBio, Inc.
Login to view more data
100 Translational Medicine associated with IntegerBio, Inc.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 27 Jun 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 1
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
IB-001
 ( BAG3 )		Hepatitis B, Chronic
More
Phase 1
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free